Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Giuliani

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trialN Normanno, R Esposito Abate, M Lambiase, et al.
La Clinica Terapeutica|August 12, 2006
[Clinical guidelines for the management of gastrointestinal stromal tumors]M Lopez, A Comandone, V Adamo, et al.
Royal Society Open Science|April 1, 2022
Detection and estimation of <i>Mastigimas anjosi</i> (Hemiptera: Calophyidae) populations on <i>Cedrela fissilis</i> treesMarcelle C do N Prado, Graziella K F Giuliani, Thais C Ghiotto, et al.
Radiation Protection Dosimetry|May 30, 2019
THE TOP-IMPLART PROTON LINEAR ACCELERATOR: INTERIM CHARACTERISTICS OF THE 35 MEV BEAMC De Angelis, A Ampollini, G Bazzano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2014
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trialF Ciardiello, N Normanno, E Maiello, et al.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2016
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOXF Ciardiello, N Normanno, E Martinelli, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 29, 2016
The antepartum stillbirth syndrome: risk factors and pregnancy conditions identified from the INTERGROWTH-21<sup>st</sup> ProjectJ E Hirst, J Villar, C G Victora, et al.
ESMO Open|August 30, 2017
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trialE Martinelli, C Cardone, T Troiani, et al.
Physical Review Letters|September 7, 2019
First Measurement of the Total Neutron Cross Section on Argon between 100 and 800 MeVB Bhandari, J Bian, K Bilton, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2017
RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trialN Normanno, R Esposito Abate, M Lambiase, et al.
La Clinica Terapeutica|August 12, 2006
[Clinical guidelines for the management of gastrointestinal stromal tumors]M Lopez, A Comandone, V Adamo, et al.
Royal Society Open Science|April 1, 2022
Detection and estimation of <i>Mastigimas anjosi</i> (Hemiptera: Calophyidae) populations on <i>Cedrela fissilis</i> treesMarcelle C do N Prado, Graziella K F Giuliani, Thais C Ghiotto, et al.
Radiation Protection Dosimetry|May 30, 2019
THE TOP-IMPLART PROTON LINEAR ACCELERATOR: INTERIM CHARACTERISTICS OF THE 35 MEV BEAMC De Angelis, A Ampollini, G Bazzano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 20, 2014
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next-generation sequencing: findings from the CAPRI-GOIM trialF Ciardiello, N Normanno, E Maiello, et al.
ESMO Open|June 10, 2026
Anti-EGFR-based maintenance versus stop and go in patients with left-sided, non-MSI-H, RAS/BRAF-wt metastatic colorectal cancer: individual patient data pooled analysisA Raimondi, G Tinè, V Boige, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2016
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOXF Ciardiello, N Normanno, E Martinelli, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 29, 2016
The antepartum stillbirth syndrome: risk factors and pregnancy conditions identified from the INTERGROWTH-21<sup>st</sup> ProjectJ E Hirst, J Villar, C G Victora, et al.
ESMO Open|August 30, 2017
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trialE Martinelli, C Cardone, T Troiani, et al.
Physical Review Letters|September 7, 2019
First Measurement of the Total Neutron Cross Section on Argon between 100 and 800 MeVB Bhandari, J Bian, K Bilton, et al.
Pageof 15